Printer Friendly
The Free Library
19,604,530 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Availability of Reimbursement Options Drives Demand for Stents in Asia.


DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c46317) has announced the addition of "Market Analysis of Coronary & Peripheral Vascular Stents in Selected Asian Regions" to their offering.

This Frost & Sullivan research service covers the Market Analysis of Coronary & Peripheral Vascular Stents in selected Asian Countries Noun 1. Asian country - any one of the nations occupying the Asian continent
Asian nation

country, land, state - the territory occupied by a nation; "he returned to the land of his birth"; "he visited several European countries"
 and provides an overview of the vascular stents market, the market drivers and restraints, as well as market forecasts from 2005-2012. In this research service, Frost & Sullivans expert analysts thoroughly examine the following markets: coronary and peripheral vascular stents market.

The following technologies are covered in this research:

* Coronary and peripheral stents

* Drug-eluting stents In cardiology, a drug-eluting stent is a stent (a scaffold) placed into narrowed, diseased coronary arteries that slowly releases a drug to block cell proliferation. This prevents scar-tissue–like growth that, together with clots (thrombus), could otherwise block the stented  

Across Asia, there has been an increase in the usage of drug-eluting coronary and peripheral stents, especially in developed countries such as Taiwan and Singapore where the availability of easy reimbursement Reimbursement

Payment made to someone for out-of-pocket expenses has incurred.
 options for higher-priced drug-eluting stents make them affordable for patients. Reimbursements by national medical savings schemes play a crucial role in the Philippines and South Korea mainly because of greater preference for lower-priced drugs, wherever available.

One of the major challenges faced by stent stent (stent)
1. a device or mold of a suitable material, used to hold a skin graft in place.

2. a slender rodlike or threadlike device used to provide support for tubular structures that are being anastomosed, or
 manufacturers is to convince national health insurance authorities to include drug-eluting stents in their list of devices warranting reimbursement. Nevertheless, the high incidence of cardiovascular diseases Cardiovascular disease
Disease that affects the heart and blood vessels.

Mentioned in: Lipoproteins Test

cardiovascular disease 
 - coronary atherosclerosis atherosclerosis (ăth'ərōsklərō`sĭs): see arteriosclerosis.
atherosclerosis
 or hardening of the arteries
, ischaemic heart disease Ischaemic (or ischemic) heart disease, or myocardial ischemia, is a disease characterized by reduced blood supply to the heart. It is the most common cause of death in most western countries.

Ischaemia means a "reduced blood supply".
, and hypertension - in Asia and the growing preference of surgeons to use stents to treat diseases such as atherosclerosis are likely to boost the acceptance of stents in the region, says the analyst of this research service.

Increasing Incidence of Cardiovascular Diseases Fuels Demand for Stents

Cardiovascular diseases have been cited as one of the top five causes of growing morbidity in most Asian countries, points out the analyst. These incidence rates, coupled with the rapidly ageing population in Asian countries, are expected to increase medical treatment requirements, which In turn can drive the growth of the vascular stents market.

With robust economic growth and a greater adoption of social security schemes, more patients are likely to have access to treatments that can enhance their quality of life. Rising consolidation within the market, increasing uptake of drug-eluting stents, and higher acceptance of expensive medical products are also likely to propel pro·pel  
tr.v. pro·pelled, pro·pel·ling, pro·pels
To cause to move forward or onward. See Synonyms at push.



[Middle English propellen, from Latin
 the need for stents across Asia.

For more information visit http://www.researchandmarkets.com/reports/c46317

Source: Frost & Sullivan
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Dec 1, 2006
Words:377
Previous Article:Increased Incidence and Prevalence of Infectious Disease Encourage the Adoption of NAT Technology in Singapore.
Next Article:Development of the Real Estate Industry Aiding Market Growth in the Chinese Wood Coatings Market.
Topics:



Related Articles
Things just mesh: making stents even better at keeping arteries open.
Home care comes of age: a place of its own in the continuum of long term care. (Home Care).
Coated inserts keep vessels unclogged.
Serial attached SCSI and serial ATA seek their levels.
Primed for growth: health savings accounts, which offer many advantages over other consumer-driven health plans, are likely to gain momentum in 2005.
Medtronic were the Leading Company in the Cardiac Rhythm Management Industry Accounting for 47% of the Market.
Medtronic Micro-Driver Coronary Stent Approved in Japan.
Significant Advances In Non Invasively Imaging The Carotid Artery And Cerebral Neurovasculature Are Allowing For Doctors To Identify Potential Stroke...
Budgetary Restraints Affect Growth of Drug Eluting Stents.
MIV Therapeutics Announces Addition of Eight New Approved Products Following Recent Acquisition of India-Based Stent Manufacturer.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles